Company intelligence / Profile preview

Appsens

Ownership: Private
Development stage: Commercial

Overview

Appsens has developed and commercialized the ECG247 smart heart sensor, a wearable medical device for continuous heart rhythm monitoring. The system uses advanced algorithms and artificial intelligence for cloud-based data processing. It is used in hospitals, specialist clinics, general practice settings across Europe and Asia, and is available in pharmacies and online shops in several countries.

Therapeutic areas: Cardiovascular
Modalities: DeviceDigital health solution
Industry: Physiological Monitoring

Partnerships

Supported by Innovation Norway and the Norwegian Research Council

Beyond the preview

Go deeper on Appsens.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Appsens.

Explore the full profile